WO2017216641A2 - Dispositifs à effet de champ dont la grille est constituée par un fluide polaire - Google Patents
Dispositifs à effet de champ dont la grille est constituée par un fluide polaire Download PDFInfo
- Publication number
- WO2017216641A2 WO2017216641A2 PCT/IB2017/001003 IB2017001003W WO2017216641A2 WO 2017216641 A2 WO2017216641 A2 WO 2017216641A2 IB 2017001003 W IB2017001003 W IB 2017001003W WO 2017216641 A2 WO2017216641 A2 WO 2017216641A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- field effect
- effect transistor
- polar fluid
- nanoscale material
- polar
- Prior art date
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 127
- 230000005669 field effect Effects 0.000 title claims abstract description 60
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 94
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 82
- 238000000034 method Methods 0.000 claims abstract description 32
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 112
- 230000004044 response Effects 0.000 claims description 100
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 94
- 239000008103 glucose Substances 0.000 claims description 82
- 210000004243 sweat Anatomy 0.000 claims description 65
- 239000002086 nanomaterial Substances 0.000 claims description 52
- 235000014655 lactic acid Nutrition 0.000 claims description 47
- 239000004310 lactic acid Substances 0.000 claims description 47
- 229920000642 polymer Polymers 0.000 claims description 41
- 239000012491 analyte Substances 0.000 claims description 36
- 229910052751 metal Inorganic materials 0.000 claims description 29
- 239000002184 metal Substances 0.000 claims description 29
- 239000000758 substrate Substances 0.000 claims description 29
- MWEKPLLMFXIZOC-UHFFFAOYSA-N pyren-1-ylboronic acid Chemical compound C1=C2C(B(O)O)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 MWEKPLLMFXIZOC-UHFFFAOYSA-N 0.000 claims description 25
- 108020003175 receptors Proteins 0.000 claims description 24
- 102000005962 receptors Human genes 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 19
- 230000008859 change Effects 0.000 claims description 17
- 108020004414 DNA Proteins 0.000 claims description 14
- 102000053602 DNA Human genes 0.000 claims description 10
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 10
- 108091023037 Aptamer Proteins 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 8
- 239000000976 ink Substances 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 125000003118 aryl group Chemical group 0.000 claims description 6
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 239000002041 carbon nanotube Substances 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 5
- 239000003792 electrolyte Substances 0.000 claims description 5
- 229910003472 fullerene Inorganic materials 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 229910010272 inorganic material Inorganic materials 0.000 claims description 5
- 239000011147 inorganic material Substances 0.000 claims description 5
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 5
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 5
- QHAXDWSSXNJXCP-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione pyrene Chemical compound ON1C(=O)CCC1=O.c1cc2ccc3cccc4ccc(c1)c2c34 QHAXDWSSXNJXCP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052582 BN Inorganic materials 0.000 claims description 4
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 claims description 4
- 206010050337 Cerumen impaction Diseases 0.000 claims description 4
- 102000004127 Cytokines Human genes 0.000 claims description 4
- 108090000695 Cytokines Proteins 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229920001222 biopolymer Polymers 0.000 claims description 4
- 210000002939 cerumen Anatomy 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229960000890 hydrocortisone Drugs 0.000 claims description 4
- 239000002207 metabolite Substances 0.000 claims description 4
- 229910052961 molybdenite Inorganic materials 0.000 claims description 4
- CWQXQMHSOZUFJS-UHFFFAOYSA-N molybdenum disulfide Chemical compound S=[Mo]=S CWQXQMHSOZUFJS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052982 molybdenum disulfide Inorganic materials 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- 210000002381 plasma Anatomy 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 239000002096 quantum dot Substances 0.000 claims description 4
- 210000003296 saliva Anatomy 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 230000008685 targeting Effects 0.000 claims description 4
- 210000002700 urine Anatomy 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 120
- 239000011780 sodium chloride Substances 0.000 description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 60
- 239000010410 layer Substances 0.000 description 55
- 230000035945 sensitivity Effects 0.000 description 25
- 238000005259 measurement Methods 0.000 description 24
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- 238000007306 functionalization reaction Methods 0.000 description 18
- 230000037081 physical activity Effects 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 11
- 239000002131 composite material Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 7
- 230000002596 correlated effect Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 230000001846 repelling effect Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 229920005570 flexible polymer Polymers 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- 210000000106 sweat gland Anatomy 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 230000003190 augmentative effect Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 229910002804 graphite Inorganic materials 0.000 description 3
- 239000010439 graphite Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 229920000307 polymer substrate Polymers 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 3
- 229910010271 silicon carbide Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 229910000927 Ge alloy Inorganic materials 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229910000676 Si alloy Inorganic materials 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- DBDNZCBRIPTLJF-UHFFFAOYSA-N boron(1-) monohydride Chemical compound [BH-] DBDNZCBRIPTLJF-UHFFFAOYSA-N 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 238000010963 scalable process Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- -1 silk Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/06—Investigating concentration of particle suspensions
- G01N15/0656—Investigating concentration of particle suspensions using electric, e.g. electrostatic methods or magnetic methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4145—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS specially adapted for biomolecules, e.g. gate electrode with immobilised receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4146—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS involving nanosized elements, e.g. nanotubes, nanowires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Definitions
- the invention disclosed herein generally relates to the design, making and applications of nanoscale field effect transistors (NFETs) gated by polar fluids, in particular graphene field effect transistors (GFETs).
- NFETs nanoscale field effect transistors
- GFETs graphene field effect transistors
- the present disclosure also relates generally to chemical and biological sensing using field effect transistors and more particularly to biochemical sensing using field effect transistors with a bio-chemically sensitive channel involving graphene.
- the field-effect transistor is a transistor that uses an electric field to control the electrical behavior of the device.
- a FET has three terminals (e.g., source, drain, and gate) and an active channel. Though the active channel, e.g., formed by a semi- conductive material, charge carriers (electrons or holes) flow from the source to the drain.
- Source (S) is where the carriers enter the channel.
- Drain (D) is where the carriers leave the channel.
- Drain-to-source voltage is VDS, and source to drain current is IDS.
- Gate (G) modulates the channel conductivity by applying a gate voltage (VG) to control a current between source and drain.
- Nanoscale field effect transistors such as graphene field effect transistors (GFETs) are widely used in numerous applications such as in bioprobes, implants, and etc.
- a field effect transistor comprises: a drain electrode; a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer arranged on the substrate, the nanoscale material layer partially defining an electrically conducting and chemically sensitive channel, the nanoscale material layer and the channel extending between and being electrically connected to the drain electrode and source electrode; and a polar fluid induced gate terminal created by a polar fluid exposed to the nanoscale material layer.
- the polar fluid comprises the target analyte.
- the polar fluid has a charge concentration sufficient to induce a polar fluid gate voltage that optimizes the gate voltage versus channel current characteristics of the field effect transistor in response to the target analyte
- a constant current or a constant voltage is applied between the source and drain electrodes, provided by a constant current source or a constant voltage source.
- the nanoscale material comprises graphene, CNTs, MoS2, boron nitride, metal dichalcogenides, phosphorene, nanoparticles, quantum dots, fullerene, 2D nanoscale material, 3D nanoscale material, 0D nanoscale material, ID nanoscale material or any combination thereof.
- the polar fluid comprises a solution with polar molecules , a gas with polar molecules, a target sensing analyte, or combinations thereof.
- the polar fluid comprises sweat, breath, saliva, earwax, urine, semen, blood plasma, a bio-fluid, a chemical fluid, an air sample, a gas sample, or a combination thereof.
- the target analyte comprises an electrolyte, glucose, lactic acid, IL6, a cytokine, HER2, Cortisol, ZAG, cholesterol, vitamins, a protein, a drug molecule, a metabolite, a peptides, an amino acid, a DNA, an RNA, an aptamer, an enzyme, a biomolecule, a chemical molecule, a synthetic molecule, or combinations thereof.
- the field effect transistor further comprises: a receptor layer deposited on the nanoscale material layer, wherein the receptor layer comprises receptors targeting the target analyte.
- the receptors comprise pyrene boronic acid (PBA), pyrene N-hydroxysuccinimide ester (Pyrene- HS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNAs (ssDNAs), aptamers, inorganic materials, synthetic molecules, biological molecules.
- the field effect transistor further comprises: a back polymer layer under the nanoscale material layer to provide support for additional mechanical, electrical, chemical, biological functionality or combinations thereof .
- the back polymer layer comprises: carbon polymers, bio polymers, PMMA, PDMS, flexible glass, nanoscale materials, silica gel, silicone, inks, printed polymers or any combination thereof.
- a method for sensing a target analyte in a polar fluid comprises: exposing the polar fluid sample to a field effect transistor, where the field effect transistor comprises: a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer arranged on the substrate, the nanoscale material layer at least partially defining an electrically conducting and chemically sensitive channel, the nanoscale material layer and the channel extending between and being electrically connected to the drain electrode and source electrode; and a polar fluid induced gate terminal created by the polar fluid exposed to the nanoscale material layer, wherein the polar fluid comprises the target analyte and has charge concentration sufficient to induce a polar fluid gate voltage that optimize the gate voltage versus channel current characteristics of the field effect transistor for detecting the analyte; measuring a first source-drain voltage at a first time point and a second source-drain voltage at a second and subsequent time point; and determining a concentration of the target analyt
- the nanoscale material comprises graphene, CNTs, MoS2, boron nitride, metal dichalcogenides, phosphorene, nanoparticles, quantum dots, fullerene, 2D nanoscale material, 3D nanoscale material, 0D nanoscale material, ID nanoscale material or any combination thereof.
- the field effect transistor is functionalized with a receptor layer deposited on the nanoscale material layer, and wherein the receptor layer comprises receptors targeting the target analyte.
- the receptors comprise pyrene boronic acid (PBA), pyrene N-hydroxysuccinimide ester (Pyrene-NHS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNAs (ssDNAs), aptamers, inorganic materials, synthetic molecules, biological molecules.
- the target analyte comprises an electrolyte, glucose, lactic acid, IL6, a cytokine, HER2, Cortisol, ZAG, cholesterol, vitamins, a protein, a drug molecule, a metabolite, a peptides, an amino acid, a DNA, an RNA, an aptamer, an enzyme, a biomolecule, a chemical molecule, a synthetic molecule, or combinations thereof.
- the polar fluid comprises a solution with polar molecules , gas with polar molecules, target sensing analyte or combinations thereof.
- the method further comprises calculating a fractional change between the first and second source-drain voltages.
- the method further comprises: applying a constant current between the source and drain electrodes of the field effect transistor.
- the method further comprises: applying a constant voltage between the source and drain electrodes of the field effect transistor.
- the polar fluid comprises sweat, breath, saliva, earwax, urine, semen, blood plasma, a bio-fluid, a chemical fluid, an air sample, a gas sample, or a combination thereof.
- the method further comprises: a back polymer layer under the nanoscale material layer to provide support for additional mechanical, electrical, chemical, biological functionality or combinations thereof .
- the back polymer layer comprises: carbon polymers, bio polymers, PMMA, PDMS, flexible glass, nanoscale materials, silica gel, silicone, inks, printed polymers or any combination thereof.
- a system comprising: a field effect transistor;
- a constant current source or a constant voltage source electrically connected with the field effect transistor comprises: a drain electrode; a source electrode; an electrically insulating substrate; a nanoscale material layer arranged on the substrate, the nanoscale material layer partially defining an electrically conducting and chemically sensitive channel, the nanoscale material layer and the channel extending between and being electrically connected to the drain electrode and source electrode; and a polar fluid induced gate terminal created by a polar fluid exposed to the nanoscale material layer.
- the polar fluid comprises the target analyte.
- the polar fluid has a charge concentration sufficient to induce a polar fluid gate voltage that optimizes the gate voltage versus channel current characteristics of the field effect transistor in response to the target analyte.
- the constant current source maintains a constant current through the field effect transistor.
- the constant voltage source maintains a constant voltage over the field effect transistor.
- a voltage output or a current output is communicated, through a wired or wireless transmission, to a digital platform.
- the digital platform comprises a smart phone, a tablet computer, a smart watch, an in-car entertainment system, a laptop computer, desktop computers, a computer terminal, a television system, e-book reader, a wearable device, or any other type of computing device that processes digital input.
- Figure 1 A depicts an embodiment of the prior art, illustrating a graphene field-effect transistor (gFET).
- gFET graphene field-effect transistor
- Figure IB depicts an embodiment of the prior art, showing current between source and drain as controlled by gate voltage.
- Figure 2A depicts an exemplary embodiment, showing a gateless graphene field-effect (g-gFET).
- g-gFET gateless graphene field-effect
- Figure 2B depicts an exemplary embodiment, showing a g-gFET.
- Figure 2C depicts an exemplary embodiment, showing a g-gFET.
- Figure 2D depicts an exemplary embodiment, showing a g-gFET.
- Figure 3 A depicts an exemplary embodiment, showing a polar fluid gate terminal (PFGT) where polar fluid has no motion.
- PFGT polar fluid gate terminal
- Figure 3B depicts an exemplary embodiment, showing a polar fluid gate terminal where polar fluid flows in a first direction.
- Figure 3C depicts an exemplary embodiment, showing a polar fluid gate terminal where polar fluid flows in a second direction.
- Figure 4A depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D with dielectric and gate metal. Gate potential is measured between the gate metal and the ground.
- Figure 4B depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D with an added metal electrode in the PFGT. Gate potential is measured between the metal electrode and the ground.
- Figure 4C depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D augmented with the dielectric and gate metal, and a metal electrode in the PFGT. Two gate potentials are measured as indicated.
- Figure 5A depicts an exemplary embodiment, showing a GFET used in conjunction with a constant current source.
- Figure 5B depicts an exemplary embodiment, showing a GFET used in conjunction with a constant voltage source.
- igure 6 illustrate an exemplary embodiment, showing selectivity
- Figure 7 illustrates an exemplary embodiment, showing sensitivity measurements for NaCl response in DI water.
- Figure 8 illustrates an exemplary embodiment, showing chloride response in sweat.
- Figure 9 illustrates an exemplary embodiment, showing selectivity measurements of Glucose response in DI water.
- Figure 10 illustrates an exemplary embodiment, showing glucose response in NaCl vs glucose response in DI water.
- Figure 11 illustrates an exemplary embodiment, showing selectivity measurements of Glucose response in NaCl water.
- Figure 12 illustrates an exemplary embodiment, showing sensitivity measurements of D-Glucose response in DI water.
- Figure 13 illustrates an exemplary embodiment, showing functionalization steps visualized through the GFET fabrication.
- Figure 14 illustrates an exemplary embodiment, showing D-glucose response in sweat.
- Figure 15 illustrates an exemplary embodiment, showing D-glucose response in blood.
- Figure 16 illustrates an exemplary embodiment, showing measurements correlation between blood glucose and sweat glucose.
- Figure 17 illustrates an exemplary embodiment, showing selectivity measurements of lactic acid response in DI water.
- Figure 18 illustrates an exemplary embodiment, showing selectivity measurements of lactic acid response in various solutions.
- Figure 19 illustrates an exemplary embodiment, showing lactic acid response in NaCl vs lactic acid response in DI water.
- Figure 20 illustrates an exemplary embodiment, showing lactic acid functionalization steps visualized through the GFET fabrication.
- Figure 21 illustrates an exemplary embodiment, showing a model for sensor correlation with sweat sodium concentration.
- Figure 22 illustrates an exemplary embodiment, showing a model for sensor correlation with sweat glucose concentration.
- Figure 23 illustrates an exemplary embodiment, showing a trans-conductance curve for PFT.
- Graphene Field Effect Transistors in General [0070] Graphene possesses a remarkable mechanical resistance; this enables thicknesses on the order of a monolayer or bilayer to be subjected to a substantial mechanical stress without losing its primary electrical properties. Such mechanical strength makes graphene an ideal candidate to replace the current generation of transparent conductive oxides (TCO), led by Indium Tin Oxide (ITO). Unlike graphene, ITO is brittle and susceptible to mechanical stress; however its low sheet resistance and high transparency are enough to offset its high material costs. The production of large area and low sheet resistance graphene sheets, on the other hand, is a relatively straightforward and scalable process using chemical vapor deposition (CVD), yielding few atomic layers with transparency higher than 90% and sheet resistances lower than 100 after proper treatment.
- CVD chemical vapor deposition
- Graphene FETs are generally fabricated on a Si wafer covered with a Si02 layer, and graphene forms the transistor channel.
- the graphene transistor consists of three terminals: source and drain metal electrodes contacting the graphene channel and a global back gate enabled by the doped Si substrate.
- Figure IB illustrates electric current between the source and drain as controlled by gate voltage.
- the resulting curve of current flow the source and drain takes a "V" shape.
- I D S channel current
- FETs field effect transistors
- Figures 2 A through 2D depicts various embodiments of FETs that do not have a physical gate.
- Figure 2A depicts an example graphene-based FET 210, which includes a substrate 1, a source electrode 2, a drain electrode 3, receptors 4, a graphene layer 5, and back polymer 6.
- substrate 1 can be polyamide, PET, PDMS, PMMA, other plastics, silicon dioxide, silicon, glass, aluminum oxide, sapphire, germanium, gallium arsenide, indium phosphide, an alloy of silicon and germanium, fabrics, textiles, silk, paper, cellulose based materials, insulator, metal, semiconductor, can be rigid, flexible or any combination thereof.
- substrate 1 can be a silicon carbide substrate and graphene layer 5 can be epitaxially grown on the silicon carbide substrate directly by sublimation of silicon from the silicon carbide substrate ( Figure 2B).
- Source electrode 2 is the electrode region in a field-effect transitor from which majority carriers flow into the interelectrode conductivity channel.
- Exemplary material that can be used as a source electrode includes but is not limited to silver, gold, carbon, graphite ink, conductive fabrics, conductive textiles, metals, conductive materials, conductive polymers, conductive gels, ionic gels, conductive inks, non-metallic conductive materials.
- Drain electrode 3 is the electrode on the opposite side from source electrode 2.
- Exemplary material that can be used as a source electrode includes but is not limited to silver, gold, carbon, graphite ink, conductive fabrics, conductive textiles, metals, conductive materials, conductive polymers, conductive gels, ionic gels, conductive inks, non-metallic conductive materials .
- graphene layer 5 can have a uniform thickness, preferably a predetermined thickness of one or more monolayers of graphene.
- a uniform and preferably predetermined thickness provides control of the sensing properties and enables the formation of reproducible devices with low variability between individual sensors.
- graphene layer 5 can be an epitaxial layer and the graphene layer substrate may be the substrate on which the graphene layer was epitaxially grown.
- the graphene layer substrate may be the substrate on which the graphene layer was epitaxially grown.
- graphene layer 5 can be surface treated with receptors 4 for selectivity so that only selected types of analytes are detected by the graphene layer.
- Exemplary receptors 4 include but are not limited to pyrene boronic acid (PBA), N- hydroxysuccinimide ester (Pyrene- HS), organic chemicals, aromatic molecules, cyclic molecules, enzymes, proteins, antibodies, viruses, single stranded DNAs (ssDNAs), aptamers, inorganic materials, synthetic molecules, biological molecules.
- PBA pyrene boronic acid
- Pyrene- HS N- hydroxysuccinimide ester
- organic chemicals aromatic molecules
- cyclic molecules enzymes, proteins, antibodies, viruses, single stranded DNAs (ssDNAs), aptamers, inorganic materials, synthetic molecules, biological molecules.
- graphene layer 5 and/or so that certain types of chemicals are prevented from reaching the chemically sensitive channel may comprise deposition of metal particles and/or polymers.
- Back polymer 6 is used to provide mechanical support to the graphene. And when doped, can add a new modality to the sensing response.
- the back polymer can be doped with biomolecules that could also bind to specific targets and contribute to the resistance change of the transistor channel.
- Devices 220, 230 and 240 are variations of device 210.
- back polymer layer 6 is omitted.
- receptor layer 4 is omitted.
- both back polymer layer 6 and receptor layer 4 are omitted.
- a device or a base device can be any of devices 210, 220, 230, and 240.
- Graphene is an allotrope of carbon in the form of a two-dimensional, atomic- scale, hexagonal lattice in which one atom forms each vertex. It is the basic structural element of other allotropes, including graphite, charcoal, carbon nanotubes and fullerenes. It can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons.
- graphene is a monolayer of carbon atoms. Each carbon atom in graphene has four electrons. Through three of these electrons the carbon atom binds to three nearest neighboring carbon atoms to form a hexagonal lattice. For each atom, a forth electron is delocalized on the whole graphene layer, which allows the conduction of an electron current.
- FIG. 3 A depicts an exemplary embodiment, showing a polar fluid gate terminal, where the polar fluid has no motion. As depicted, charges of the polar or ionic components are redistribution in the polar fluid to create a polar fluid gate terminal (PFGT) and an induced fluid gate voltage (V F G)- This voltage can result in a shift in the x-axis (voltage) in the V-shaped current vs. fluid gate voltage curve.
- PFGT polar fluid gate terminal
- V F G induced fluid gate voltage
- a shift towards the tip of the V-shaped curve can lead better sensitivity.
- Such a shift can be caused by a polar liquid induced gate voltage.
- the polar liquid induced gate voltage is associated with the concentration of charged particles within the polar fluid.
- the concentration can reflect the total quantity of all negatively charged particles or all positively charged particles.
- the shift in the V-shaped curve can correlate with a wide range of charged particle concentrations.
- a shift is correlated with a charged particle concentration as low as 1 femto g/L (e.g., NaCl).
- a shift is correlated with a charged particle concentration as high as 300 g/L (e.g., NaCl).
- FIG. 3B depicts an exemplary embodiment, showing a polar fluid gate terminal, where the polar fluid flows in a first direction.
- the magnitude of the gate potential (V F G) will be directly proportional to the flow rate of the polar fluid.
- the sign or direction of V F G will depend on the direction of flow of the polar fluid; e.g., along the source drain terminal and across the source drain terminal. For example, if the gate voltage is positive along the source drain direction, it will be negative in the reverse direction, and vice versa.
- the polar fluid is flowing across the source drain voltage, if the gate voltage is positive along the Y direction, it will be negative in the -Y direction and vice versa.
- the direction of the polar fluid flow changes, the direction of the gate voltage would also change.
- Figure 3C depicts an exemplary embodiment, showing a polar fluid gate terminal, where the polar fluid flows in a second direction opposite to the first direction. Detecting Gate Voltage at Polar fluid gate terminal
- Figures 4A through 4C illustrate set up by which gate voltage at a polar fluid gate terminal (PFGT) is determined.
- PFGT polar fluid gate terminal
- Figure 4A depicts an exemplary embodiment, showing a base device with a dielectric layer 7 and a gate metal 8.
- the base device can be any of the devices depicted in Figures 2A-2D such as 210, 220, 230 and 240.
- Gate potential is measured between the gate metal and the ground.
- Dielectric layer 7 is added underneath the substrate of the base device (e.g., substrate 1 as depicted in Figures 2A through 2D).
- Gate metal 8 is added underneath dielectric layer 7.
- Gate metal 8 is added only to measure the induced gate voltage, no voltage will be applied through gate metal 8.
- Vgl can vary in non-linear way depending on the PFGT device characteristics and type of channel. For example, if the channel is graphene (ambipolar), Vgl can follow the transconductance response typical to a graphene device.
- Figure 4B depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D with an added metal electrode in the PFGT. Gate potential is measured between the metal electrode and the ground.
- Vg2 is the top gate voltage formed by the double layer capacitance between added metal electrode and active channel. Vg2 can vary in non-linear way depending on the PFGT device characteristics and type of channel. For example if the channel is graphene (ambipolar), thenVg2 will follow the transconductance response typical to a graphene device (see, e.g., Figure 23).
- Figure 4C depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D augmented with the dielectric and gate metal, and a metal electrode in the PFGT.
- Two gate potentials are measured as indicated.
- the two gate potentials (Vgl and Vg2) are electrical outputs that are modulated using the source drain current/voltage and the induced PFG.
- the simultaneous measurements of Vgl and Vg2 creates a tri -gated structure that can used develop next generation microprocessors, logic gates, computational circuits, radio frequency (RF) devices, sensors, and etc.
- RF radio frequency
- Figure 4C depicts an exemplary embodiment, showing a base device as depicted in Figures 2A-2D augmented with the dielectric and gate metal, and a metal electrode in the PFGT.
- Two gate voltages e.g., Vgl and Vg2 are supplied to the PFGT to modulate the overall electrical characteristics of the PFGT device for a desired application.
- the simultaneous modulation by Vgl and Vg2 creates a tri-gated structure that can used to shift the device operation to a desired electrical performance in a more controlled fashion using minimal energy.
- Such a device can be utilized to develop next generation microprocessors, logic gates, computational circuits, radio frequency (RF) devices, sensors, and etc.
- RF radio frequency
- Figure 5 A depicts an exemplary embodiment, showing a circuit used for sensor readout via a polar fluid graphene field effect transistor (PFGFET).
- PFGFET polar fluid graphene field effect transistor
- Ic constant current
- VOU T Output voltages
- R current limiting resistor
- FIG. 5B depicts an exemplary embodiment, showing another circuit used for sensor readout via PFGFET.
- a constant voltage (Vs) is supplied to the PFGFET.
- Currents or chargers ( ⁇ ) are read from the PFGFET using a current limiting resistor (R). The electrical current output is then calibrated to the concentrations of the analyte being sensed.
- a polymer was disposed on graphene with thickness normally less than 0.5 mm, which was then separated from the catalytic substrate where the graphene was grown.
- a flexible polymer platform for the sensing system was used for staging the graphene polymer composite and two metal electrical contacts.
- the graphene polymer composite was bound to the flexible polymer platform.
- a solution of desired linker molecule is deposited on the graphene polymer composite to incubate. The excess linker molecule solution was removed from the graphene polymer composite; and the two metal electrical contacts were deposited on both edges of the graphene polymer composite.
- the graphene polymer complex was then placed on a polymer substrate, such as teflon, polyimide, and etc., and then heated for 1-10 mins at 80-150 degree Celsius to remove any impurities.
- a polymer substrate such as teflon, polyimide, and etc.
- the GFET sensor was then ready for use. In some cases, receptors for specific analytes were deposited on the graphene layer.
- a sensor system for analyte sensing through sweat where the sensor comprised of:
- o a graphene polymer composite bound to the flexible polymer platform; o asource electrode and a drain electrode located in a sensor configuration on
- each of the source and drain electrodes comprised of conductive metals; o graphene polymer composite layer was functionalized with a linker molecule for the desired analyte biosensing, between the two electrodes; and
- a method of determining analyte concentration through sweat comprised the following steps:
- analyte binds to the linker molecule by releasing an electron through the linker into the channel resulting in change in potential across the channel;
- Figure 6 shows that the GFET gave no significant response to just DI water and a linear response to increasing NaCl concentrations in DI water. The increasing
- concentrations changed the voltage across the channel, thereby showing high selectivity towards NaCl in DI water as control.
- Sensitivity Response of various NaCl concentrations in DI water were also measured on the GFET to study the sensitivity range of the sensor towards NaCl. Solutions with exponentially increasing concentrations of NaCl, ranging from 0. lng/dl to 10 mg/dL in DI water, were prepared. The test started with introducing 2ul of the lowest concentrations on the GFET followed by the next higher concentration after 3 minutes and so on. Here, concentrations increased logarithmically, for example, going from O. lng/dl to lng/dl, then lOng/dl, then
- Figure 7 shows that the GFET gave no significant response to just DI water and an exponential response starting from the lowest to the highest concentration of NaCl in DI water. The increasing concentrations changed the voltage across the channel, thereby showing high sensitivity around 250 femto gram/litre towards NaCl in DI water as control.
- Chloride Response in Sweat Measurement of chloride concentrations in human sweat was done with human subjects. The test required the subject to perform physical activity, such as running, and taking water for hydrating from time to time.
- Figure 8 shows the real-time concentrations of sweat osmolality of two human subjects using a PFGFET attached to the skin.
- the osmolality concentrations in sweat directly correlated to the physical performance of the individuals.
- Subject 1 was a sprinter and subject 2 was a jogger.
- the sprinter (subject 1) ran the same distance in a quicker pace (run 1) as compared to the jogger (subject 2 and run 2). It was observed that more intense a subject's physical activity, higher the measured body osmolality concentrations. Peaks in body osmolality were observed during periods of most intense physical activity. It was also observed that the body osmolality reduced during periods of the intense physical activity.
- High sensitivity The GFETs functionalized with PBA exhibited a high sensitivity for NaCl with a limit of detection (LOD) of 250 femto gram/litre.
- LOD limit of detection
- the GFET sensors have a high signal to noise ratio, are highly selective and due to the high surface area for bonding there is higher bonding between the surface and the molecules. All these factors play a huge differentiating role, making GFETs highly sensitive.
- Graphene FETs were functionalized with linker molecule (lock) that specifically binds to the glucose molecule in fluids.
- linker molecule lock
- the GFET was functionalized with Pyrene Boronic Acid (PBA). Pyrene Boronic Acid bonds to the Graphene surface using pi-pi bond. PBA forms a reversible boron-anion complex with D- glucose. Fabrications steps are the following:
- a polymer was disposed on graphene with thickness normally less than 0.5mm, which is then separated from the catalytic substrate it was grown on.
- the graphene polymer complex was then placed on a polymer substrate, such as teflon, polyimide, etc. and heated for 1-10 mins at 80-150 degree Celsius to remove any impurities,
- Figure 9 shows that the GFET gave no significant response to just DI water or to lactose solutions and an exponential response to increasing D-Glucose concentrations in DI water. The increasing concentrations changed the voltage across the channel, thereby showing high selectivity towards D-Glucose with DI water as control.
- Glucose Response in NaCl vs Glucose Response in DI water Response of various D-Glucose concentrations in DI water and NaCl solutions were measured on the GFET to study the sensitivity of the functionalized sensor towards D-Glucose in DI water vs D-Glucose in NaCl and to understand the effect of NaCl solutions.
- Figure 10 shows that the D-Glucose response in NaCl is more amplified than D-Glucose response in DI water.
- the polar solution providing the PFGT on the GFET amplified the electrical response across the channel thereby increasing sensitivity and providing reversibility.
- Figure 11 shows that the GFET gave no significant response to just NaCl solutions and a linear response to solutions of increasing D-Glucose concentrations in fixed NaCl concentration versus solutions of increasing NaCl concentrations. The increasing concentrations changed the voltage across the channel, thereby showing high selectivity towards D-Glucose.
- the GFETs (NFETs) functionalized with PBA gave a highly selective response (>95%) to glucose concentrations.
- Figure 11 gives an idea that the functionalized glucose sensor isn't sensitive to NaCl (as the orange curve is fairly flat), whereas the glucose curve is increasing with increasing cone of glucose present in NaCl solution.
- concentrations on the GFET followed by the next higher concentration after 3 minutes and so on.
- concentrations increased logarithmically; e.g., from 0.25pg/l, then 2.5pg/l and so on. This was continued until all the concentrations were introduced onto the GFET.
- Figure 12 shows that the GFET gave no significant response to just DI water and a linear response starting from the lowest to the highest concentration, with increasing concentrations the current across the channel changed, thereby showing high sensitivity around 250 femto gram/litre (i.e., 1.38e "12 mmol/1) towards D-glucose.
- FIG. 13 Shown in Figure 13 are the current response for graphene sensor, before functionalization, after functionalization and after glucose is introduced on the sensor. This helps in understanding each stage of the GFET fabrication step and how after each stage the current response of the GFET changes. For example, it was shown in Figure 13 that the current response increases after functionalization (orange) as compared to the before functionalization (blue) this happens because linker molecules are bound by pi-pi bond and the overall charge on the surface of the graphene increases. The linker molecule attracts the glucose molecules and binds to it by using these charge clouds thereby reducing the current on the GFET as compared to its previous state.
- D-glucose Response in Sweat and Blood Measurement of glucose concentrations in human sweat was done with human subjects. The test required the subject to perform physical activity, such as running, and taking blood samples to measure blood glucose using a blood glucose meter every few minutes. The GFETs are worn on the fore arm and lower back (eccrine sweat glands) by human subjects. Electrical responses due to the D-Glucose concentrations in sweat were transmitted and recorded continuously (every 500 milliseconds) while the subjects were performing intense physical activity (like running).
- the physical activity was eating food.
- his glucose will start going up as can be seen in both sweat and blood glucose.
- the glucose level will start to come down and stabilize.
- Figure 14 shows_the change in D-Glucose concentration in sweat, as represented by the fractional change in the voltage.
- the blood glucose data in Figure 15 was also plotted against time for the entire duration of the workout.
- the sweat glucose measurements were correlated with blood glucose measurements.
- the sweat glucose values for the corresponding blood glucose values were plotted against blood (blood vs sweat) to get a correlation R 2 , which provided an idea about how well sweat glucose matched with blood glucose.
- Figure 16 further shows measurements correlation between blood glucose and sweat glucose.
- 3 different sensors were used for the same person for the same time.
- Over 150 curves of sweat glucose were collected from 10 human subjects along with their blood glucose for the entire duration of the study, for correlation. The subjects performed physical activities (workouts, running, etc.) or no physical activity (sitting on a desk, etc.).
- the GFETs functionalized with PBA exhibited a high sensitivity for D-Glucose with a limit of detection (LOD) of 250 femto gram/litre, i.e., 1.38e "12 mmol/1.
- the existing glucose meters have an LOD between 0.3-1. lmmol/1.
- the GFET functionalized with PBA is approx. 1010 times more sensitive than the existing standard glucose measurement devices.
- the GFET sensors have a high signal to noise ratio, are highly selective and due to the high surface area for bonding there is higher bonding between the surface and the receptor molecules. All these factors play a huge differentiating role in making GFETs highly sensitive.
- Graphene FETs were functionalized with linker molecule (lock) that specifically binds to the lactic acid molecules in fluids.
- linker molecule lock
- the GFET was functionalized with Lactate Oxidase( LOx) to the Graphene surface using an intermediate pyrene- HS linking chemistry
- a polymer is disposed on graphene with thickness normally less than 0.5mm, which is then separated from the catalytic substrate it was grown on.
- the graphene polymer complex is then placed on a polymer substrate, such as teflon, polyimide, etc. and heated for 1-10 mins at 80-150 degree celcius to remove any impurities,
- the senor is ready for use.
- Figure 17 shows that the GFET gave no significant response to just DI water and a polynomial response to increasing lactic acid concentrations in DI water, the increasing concentrations changed the voltage across the channel, thereby showing high selectivity towards lactic acid in DI water, using DI water as the control.
- Selectivity Measurements of Lactic Acid Response in Various Solutions Response of various lactic acid concentrations in various solutions were measured on the GFET to study the sensitivity of the functionalized sensor towards lactic acid and response on a non- functionalized sensor. Solutions with varying concentrations of lactic acid ranging for 0-25mM in NaCl and NaCl-Glucose were prepared. The test started with introducing 2ul of the lowest concentrations on the GFET followed by the next highest concentration after 3 minutes and so on. This was continued until all the concentrations were introduced onto the GFET, separately for each solution.
- Figure 18 shows that the GFET gave no significant response to just NaCl or NaCl-Glucose control and a polynomial response to increasing lactic acid concentrations in NaCl and NaCl-Glucose solution. The increasing concentrations changed the voltage across the channel, thereby showing high selectivity towards lactic acid. There was no significant response on the non-functionalized sensor for the lactic acid NaCl solution, further emphasizing on the selectivity and sensitivity of the sensor towards lactic acid.
- Lactic Acid Response in NaCl vs. Lactic Acid Response in DI Water:
- Figure 19 shows that the lactic acid response in NaCl is less amplified than lactic acid response in DI water.
- Figure 20 The current responses for graphene sensor, before functionalization, after functionalization and after lactic acid is introduced on the sensor are depicted in Figure 20. This helps in understanding each stage of the GFET fabrication step and how after each stage the current response of the GFET changes. For example, Figure 20 shows that the current response decreases after functionalization (orange) as compared to before functionalization (blue). The linker molecule attracts the lactic acid molecules and binds to it thereby reducing the current on the GFET as compared to its previous state.
- the GFETs functionalized with Pyrene NHS exhibited a high sensitivity for lactic acid with a limit of detection (LOD) of 250 femto gram/litre; i.e., 2.78e- 12 mmol/1.
- the existing lactic acid meters have an LOD between 0.001-10 mmol/1.
- the GFET functionalized with Pyrene NHS is approx. 108 times sensitive than the existing standard lactic acid measurement devices.
- the GFET sensors have a high signal to noise ratio, are highly selective and due to the high surface area for bonding there is higher bonding between the surface and the receptor molecules. All these factors play a huge differentiating role in making GFETs highly sensitive.
- Sweat Salt Concentration Correlation Figure 21 represents, the sweat sensor response for a corresponding sweat sodium concentration.
- Increasing concentrations of NaCl 0.1 mg/dl to 100 mg/dl were added on the graphene sensor, every 3 minutes. The test started with dropping 2 ul of the lowest concentration (e.g., 0.1 mg/dl) followed by the next higher concentration (e.g., 0.2 mg/dl) and so on with an interval of 3 minutes.
- Corresponding fractional change in voltage was measured. This was repeated for 10 different sensors and a max error of 15% was observed. This acts as a model for correlation between sweat sodium and corresponding change in voltage.
- NaCl solution with increasing concentrations ranging from 0.1 ng/dl to 1 mg/dl is dropped every 3 minutes on the sensor.
- the test starts with dropping 2 ul of the lowest concentration (e.g., 0.1 ng/dl) followed by the next higher concentration (1 ng/dl) and so on with an interval of 3 minutes.
- both the debye length and the gating effect are a function of the concentration of the polar molecules.
- DI is more dominant, due to which more holes are created and we see a drop in the voltage.
- the concentration of the NaCl increasing in the solution it becomes more dominant and more electrons are created near the debye layer, thereby showing an increase in the voltage.
- the numbers expressing quantities of ingredients, properties such as molecular weight, reaction conditions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified in some instances by the term "about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Thin Film Transistor (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019518162A JP7129405B2 (ja) | 2016-06-30 | 2017-06-30 | 極性流体がゲートの電界効果デバイス |
CN201780050922.5A CN109642888B (zh) | 2016-06-30 | 2017-06-30 | 极性流体门控场效应器件 |
CA3067304A CA3067304C (fr) | 2016-06-18 | 2017-06-30 | Dispositifs a effet de champ dont la grille est constituee par un fluide polaire |
KR1020247010269A KR20240045375A (ko) | 2016-06-30 | 2017-06-30 | 극성 유체 게이트를 갖는 전계 효과 디바이스 |
EP17812823.7A EP3472607A4 (fr) | 2016-06-30 | 2017-06-30 | Dispositifs à effet de champ dont la grille est constituée par un fluide polaire |
CN202211200989.1A CN115753941A (zh) | 2016-06-30 | 2017-06-30 | 极性流体门控场效应器件 |
KR1020197001607A KR102653287B1 (ko) | 2016-06-30 | 2017-06-30 | 극성 유체 게이트를 갖는 전계 효과 디바이스 |
US16/221,384 US20190257732A1 (en) | 2016-06-18 | 2018-12-14 | Polar fluid gated field effect devices |
JP2022107238A JP7449333B2 (ja) | 2016-06-30 | 2022-07-01 | 極性流体がゲートの電界効果デバイス |
JP2024031345A JP2024055954A (ja) | 2016-06-30 | 2024-03-01 | 極性流体がゲートの電界効果デバイス |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/351,942 | 2016-06-18 | ||
US201662356742P | 2016-06-30 | 2016-06-30 | |
US201662356729P | 2016-06-30 | 2016-06-30 | |
US62/356,742 | 2016-06-30 | ||
US62/356,729 | 2016-06-30 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/221,384 Continuation US20190257732A1 (en) | 2016-06-18 | 2018-12-14 | Polar fluid gated field effect devices |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2017216641A2 true WO2017216641A2 (fr) | 2017-12-21 |
WO2017216641A3 WO2017216641A3 (fr) | 2018-02-15 |
Family
ID=65762403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2017/001003 WO2017216641A2 (fr) | 2016-06-18 | 2017-06-30 | Dispositifs à effet de champ dont la grille est constituée par un fluide polaire |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3472607A4 (fr) |
JP (3) | JP7129405B2 (fr) |
KR (2) | KR20240045375A (fr) |
CN (2) | CN115753941A (fr) |
WO (1) | WO2017216641A2 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108181367A (zh) * | 2017-12-26 | 2018-06-19 | 湖北大学 | 一种基于石墨烯晶体管的dna传感器及其制备方法和在dna检测中的应用 |
JP2020041981A (ja) * | 2018-09-13 | 2020-03-19 | 株式会社東芝 | 有機物プローブ及び分子検出装置 |
CN112782242A (zh) * | 2019-11-07 | 2021-05-11 | 英飞凌科技股份有限公司 | 复合材料、化学电阻气体传感器与系统及制造和使用方法 |
EP4124855A1 (fr) | 2021-07-29 | 2023-02-01 | Consejo Superior De Investigaciones Científicas (CSIC) | Biocapteur en graphène pour la détection du virus de l'hépatite c |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112345614B (zh) * | 2019-08-08 | 2023-07-21 | 中国科学院微电子研究所 | 基于氮化镓基增强型器件的探测器及其制作方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4587539B2 (ja) * | 1999-09-13 | 2010-11-24 | アイメック | 有機材料に基づいてサンプル中の被分析物を検出するための装置 |
JP4891550B2 (ja) * | 2005-02-10 | 2012-03-07 | 独立行政法人科学技術振興機構 | n型トランジスタ、n型トランジスタセンサ及びn型トランジスタ用チャネルの製造方法 |
EP1999277B1 (fr) * | 2006-03-17 | 2015-07-08 | The Government of the United States of America, as represented by The Department of Health and Human Services | Appareil de capteurs liés en microréseau à base de transistors en nanotubes de carbone incluant des matériaux sondes biologiques, procédée pour son préparation et procédée de détection électronique d'un matériau cible biologique |
KR100773549B1 (ko) * | 2006-04-03 | 2007-11-07 | 삼성전자주식회사 | 동일 전계 효과 트랜지스터를 이용하여 생분자를 검출하는방법 |
US20100019226A1 (en) * | 2006-09-22 | 2010-01-28 | Koninklijke Philips Electronics N.V. | Semiconductor sensor device, diagnostic instrument comprising such a device and method of manufacturing such a device |
JP2008258594A (ja) * | 2007-03-09 | 2008-10-23 | Hokkaido Univ | カーボンナノチューブ電界効果トランジスタの製造方法およびバイオセンサ装置 |
WO2009085356A2 (fr) | 2007-10-01 | 2009-07-09 | University Of Southern California Usc Stevens | Procédés d'utilisation et de construction de plate-formes de nanocapteurs |
US8169006B2 (en) * | 2008-11-29 | 2012-05-01 | Electronics And Telecommunications Research Institute | Bio-sensor chip for detecting target material |
US8716029B1 (en) * | 2010-09-21 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The United States | Carbon nanotube sensors employing synthetic multifunctional peptides for surface functionalization |
US8853667B2 (en) | 2011-12-06 | 2014-10-07 | Jain Faquir C | Quantum dot gate FETs and circuits configured as biosensors and gene sequencers |
US8896032B2 (en) * | 2013-01-23 | 2014-11-25 | International Business Machines Corporation | Self-aligned biosensors with enhanced sensitivity |
US20160252517A1 (en) * | 2013-10-11 | 2016-09-01 | The Regents Of The University Of California | Biomolecular interaction detection devices and methods |
US9765395B2 (en) * | 2014-04-28 | 2017-09-19 | Nanomedical Diagnostics, Inc. | System and method for DNA sequencing and blood chemistry analysis |
US11121334B2 (en) * | 2014-06-26 | 2021-09-14 | Trustees Of Tufts College | 3D graphene transistor |
EP3235010A4 (fr) * | 2014-12-18 | 2018-08-29 | Agilome, Inc. | Transistor à effet de champ chimiquement sensible |
-
2017
- 2017-06-30 KR KR1020247010269A patent/KR20240045375A/ko active Search and Examination
- 2017-06-30 EP EP17812823.7A patent/EP3472607A4/fr active Pending
- 2017-06-30 JP JP2019518162A patent/JP7129405B2/ja active Active
- 2017-06-30 WO PCT/IB2017/001003 patent/WO2017216641A2/fr unknown
- 2017-06-30 KR KR1020197001607A patent/KR102653287B1/ko active IP Right Grant
- 2017-06-30 CN CN202211200989.1A patent/CN115753941A/zh active Pending
- 2017-06-30 CN CN201780050922.5A patent/CN109642888B/zh active Active
-
2022
- 2022-07-01 JP JP2022107238A patent/JP7449333B2/ja active Active
-
2024
- 2024-03-01 JP JP2024031345A patent/JP2024055954A/ja active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108181367A (zh) * | 2017-12-26 | 2018-06-19 | 湖北大学 | 一种基于石墨烯晶体管的dna传感器及其制备方法和在dna检测中的应用 |
JP2020041981A (ja) * | 2018-09-13 | 2020-03-19 | 株式会社東芝 | 有機物プローブ及び分子検出装置 |
CN112782242A (zh) * | 2019-11-07 | 2021-05-11 | 英飞凌科技股份有限公司 | 复合材料、化学电阻气体传感器与系统及制造和使用方法 |
EP3819260A1 (fr) * | 2019-11-07 | 2021-05-12 | Infineon Technologies AG | Matériau composite, capteur de gaz chimiorésistant, système de capteur de gaz chimiorésistant et son procédé de fabrication et d'utilisation |
EP4124855A1 (fr) | 2021-07-29 | 2023-02-01 | Consejo Superior De Investigaciones Científicas (CSIC) | Biocapteur en graphène pour la détection du virus de l'hépatite c |
WO2023006865A1 (fr) | 2021-07-29 | 2023-02-02 | Consejo Superior De Investigaciones Cientificas (Csic) | Biocapteur de détection du virus de l'hépatite c |
Also Published As
Publication number | Publication date |
---|---|
KR102653287B1 (ko) | 2024-03-29 |
JP7449333B2 (ja) | 2024-03-13 |
KR20240045375A (ko) | 2024-04-05 |
CN115753941A (zh) | 2023-03-07 |
JP2019525200A (ja) | 2019-09-05 |
KR20190027828A (ko) | 2019-03-15 |
JP2022121664A (ja) | 2022-08-19 |
JP7129405B2 (ja) | 2022-09-01 |
CN109642888A (zh) | 2019-04-16 |
CN109642888B (zh) | 2022-11-01 |
EP3472607A4 (fr) | 2020-02-19 |
JP2024055954A (ja) | 2024-04-19 |
WO2017216641A3 (fr) | 2018-02-15 |
EP3472607A2 (fr) | 2019-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7449333B2 (ja) | 極性流体がゲートの電界効果デバイス | |
CA3067304C (fr) | Dispositifs a effet de champ dont la grille est constituee par un fluide polaire | |
Sheibani et al. | Extended gate field-effect-transistor for sensing cortisol stress hormone | |
Hao et al. | Graphene-based fully integrated portable nanosensing system for on-line detection of cytokine biomarkers in saliva | |
Yan et al. | Solution‐gated graphene transistors for chemical and biological sensors | |
US10006882B2 (en) | Biosensing system and methods using electron-ionic mechanisms at fluid-sensor interfaces | |
US8969069B2 (en) | Glycated protein measurement sensor and portable glycated protein measurement apparatus including same | |
Kwon et al. | Nanoscale FET-based transduction toward sensitive extended-gate biosensors | |
Kotlowski et al. | Electronic biosensing with flexible organic transistor devices | |
Huang et al. | Highly manufacturable graphene oxide biosensor for sensitive Interleukin-6 detection | |
Wang et al. | High-stability pH sensing with a few-layer MoS2 field-effect transistor | |
Rollo et al. | High aspect ratio fin-ion sensitive field effect transistor: Compromises toward better electrochemical biosensing | |
Her et al. | Label-free detection of alanine aminotransferase using a graphene field-effect biosensor | |
Hossain et al. | Ultrasensitive WSe2 field-effect transistor-based biosensor for label-free detection of cancer in point-of-care applications | |
US10739305B1 (en) | Biosensing systems and methods using a FET | |
Pindoo et al. | Increased sensitivity of biosensors using evolutionary algorithm for bio-medical applications | |
Nguyen et al. | Field effect transistor based wearable biosensors for healthcare monitoring | |
Zeimpekis et al. | Dual-gate polysilicon nanoribbon biosensors enable high sensitivity detection of proteins | |
Rahmani et al. | Analytical prediction of carbon nanoscroll-based electrochemical glucose biosensor performance | |
Rani et al. | Silicon Nanowire Field-Effect Biosensors | |
Rahmani | Performance analysis of electrochemical detection platform for DNA hybridization using TGN-based nanobiosensor | |
US20220170920A1 (en) | Apparatus and method for measuring hormone concentration in biofluids | |
Hossain et al. | Micro-heater embedded ISFET pH sensor with high-k gate dielectrics for enhanced sensitivity | |
Ahmadsaidulu et al. | Design and analysis of silicon nanowire FET for the detection of cardiac troponin I biomarker | |
Aftab et al. | Nanomaterials-Based Field-Effect Transistor for Protein Sensing: New Advances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17812823 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2019518162 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20197001607 Country of ref document: KR Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17812823 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2017812823 Country of ref document: EP Effective date: 20190118 |
|
ENP | Entry into the national phase |
Ref document number: 3067304 Country of ref document: CA |